S
XBI
State Street® SPDR® S&P® Biotech…
128.96
0.41+0.32%After Hours: 128.87 -0.09 -0.07%19:58 04/02 EDT
OPEN/PREV CLOSE125.66/128.55
TODAY RANGE125.57-129.95
VOL9.90M
TOTAL ASSET8.50B
52 WEEK RANGE66.42-132.09
% TURNOVER0%
NAV129.04
EXPENSE RATIO(NET)0.35%
1Y RETURN(CUM.)60.56%
DIVIDEND0.4405
DIV YIELD0.34%
EX-DATE03/23/2026
% RANGE3.40%
INCEPTION DATE01/31/2006
BETA--
LOT SIZE1
LIPPER RATING★★★☆☆
News
Seeking Alpha·21h ago
Biotech Is Holding Steady In 2026
Seeking Alpha·1d ago
No deal yet? Trump readies 100% tariffs on select drugmakers - report
TipRanks·03/27 13:40
Unusually active option classes on open March 27th
NASDAQ·03/25 10:20
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
Barchart·03/20 08:55
How Is Bio-Techne's Stock Performance Compared to Other Biotechnology Stocks
NASDAQ·03/17 14:54
XBI, MRNA, ROIV, ACLX: Large Outflows Detected at ETF
Seeking Alpha·03/17 14:20
Geopolitically Themed Investment Risks And Opportunities Take Center Stage
TipRanks·03/17 12:45
Largest borrow rate increases among liquid names
NASDAQ·03/17 09:05
The Zacks Analyst Blog Highlights IBB, XBI, BBH and GNOM
Barron‘s·03/16 21:13
BioNTech Stock Is a Bargain. Why Its Recent Selloff Is a Buying Opportunity.
Barron‘s·03/16 20:03
Covid Vaccine Maker BioNTech Offers Cheap Biotech Play Given Huge Cash Reserves
Seeking Alpha·03/16 17:00
The Private Credit Crack Up Gathers Momentum
Same Industry
Name/Symbol
Change%
Price
No data yet, let's see others
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.